| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 06/04/2002 | US6399636 For therapy of asthma, chronic bronchitis, chronic obstructive pulmonary disease (copd), eosinophilic granuloma, psoriasis and septic shock, ulcerative colitis, crohn's disease, reperfusion injury of the myocardium and brain |
| 06/04/2002 | US6399635 N,n-diethyl-4-(n-piperidin-3-yl-anilino) benzamide compound; reductive amination of a 3-piperidone, arylation |
| 06/04/2002 | US6399609 Corticotropin releasing factor (crf) antagonists |
| 06/04/2002 | US6399603 Therapeutic heterocycles |
| 06/04/2002 | US6399598 Diheterocyclic metalloprotease inhibitors |
| 06/04/2002 | US6399590 Phosphoglycolipid and methods for its use |
| 06/04/2002 | US6399576 Administering dosage of batroxobin |
| 06/04/2002 | US6399139 Controlling material handling |
| 06/04/2002 | US6399095 Aloe leaves, freeze drying and vacuum drying |
| 06/04/2002 | US6399079 Spill resistant pharmaceutical compositions in semi-solid form |
| 06/04/2002 | CA2302396C Allosteric adenosine receptor modulators |
| 05/30/2002 | WO2002042765A1 Remedies for digestive functional disorder and screening method |
| 05/30/2002 | WO2002042484A2 Method for producing pectin hydrolysis products |
| 05/30/2002 | WO2002042455A2 Modifier of organelle metalbolism |
| 05/30/2002 | WO2002042443A2 Use of modulators of eukaryotic signal transduction pathways for the treatment of helicobacter infections |
| 05/30/2002 | WO2002042437A2 Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof |
| 05/30/2002 | WO2002042436A2 Isolated human phosphatase proteins, nucleic acid molecules encoding them, and uses thereof |
| 05/30/2002 | WO2002042332A2 Truncated cd200 |
| 05/30/2002 | WO2002042328A2 Method for studying the effects of commensal microflora on mammalian intestine and treatments of gastrointestinal-associated disease based thereon |
| 05/30/2002 | WO2002042319A2 2-substituted estrogens as antiangiogenic agents |
| 05/30/2002 | WO2002042306A1 Benzimidazole derivatives, preparation and therapeutic use thereof |
| 05/30/2002 | WO2002042301A1 Novel pyridine-substituted pyrazolopyridine derivatives |
| 05/30/2002 | WO2002042299A1 Novel lactame-substituted pyrazolopyridine derivatives |
| 05/30/2002 | WO2002042298A1 Aminothiazoles and their use as adenosine receptor antagonists |
| 05/30/2002 | WO2002042296A1 Farnesyl transferase inhibiting benzoheterocyclic derivatives |
| 05/30/2002 | WO2002042292A2 Indol derivative and their use as inhibitors of p38 kinase |
| 05/30/2002 | WO2002042291A1 4-(biphenylcarbonylamino)piperidine derivatives as mtp inhibitors |
| 05/30/2002 | WO2002042280A2 Pyrimidine derivatives |
| 05/30/2002 | WO2002042278A2 Imidazole and benzimidazole caspase inhibitors and uses thereof |
| 05/30/2002 | WO2002042273A2 Acid derivatives useful as serine protease inhibitors |
| 05/30/2002 | WO2002042269A1 3-arylindole derivatives and their use as cb2 receptor agonists |
| 05/30/2002 | WO2002041919A1 Freeze-dried pantoprazole preparation and pantoprazole injection |
| 05/30/2002 | WO2002041918A2 Use of a triple combination comprising a 5ht3 antagonist, a 5ht4 agonist and a laxative for promoting intestinal lavage |
| 05/30/2002 | WO2002041912A1 Drugs and foods improving the quality of life and process for producing the same |
| 05/30/2002 | WO2002041908A1 Process for preparing aqueous extracts of plants and extracts so obtained |
| 05/30/2002 | WO2002041896A2 Use of thienopyrimidines |
| 05/30/2002 | WO2002041892A1 Water-soluble liquid internal medicine |
| 05/30/2002 | WO2002041884A2 Inhibitors of abc drug transporters at the blood-brain barrier |
| 05/30/2002 | WO2002041882A2 Combination comprising an agent decreasing vegf activity and an agent decreasing egf activity |
| 05/30/2002 | WO2002041880A2 Use of pyrazolo[4,3-d]pyrimidines |
| 05/30/2002 | WO2002041861A1 Rhinological agents |
| 05/30/2002 | WO2002041837A2 Treatment of mucositis |
| 05/30/2002 | WO2002041834A2 Atorvastatin hemi-calcium form vii |
| 05/30/2002 | WO2002028423A8 Stabilisation of plasmid inheritance in bacteria by preventing multimerisation |
| 05/30/2002 | WO2002022599A3 Chemokine receptor binding heterocyclic compounds |
| 05/30/2002 | WO2002020736A9 Proteases |
| 05/30/2002 | WO2002000611A3 Fmoc-l-leucine and derivatives thereof as ppar-gamma agonists |
| 05/30/2002 | WO2001098270A3 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity |
| 05/30/2002 | WO2001095928A3 Methods for regulating a cell-mediated immune response by blocking lymphocytic signals and by blocking lfa-1 mediated adhesion |
| 05/30/2002 | WO2001087979A3 Methods and compositions of matter concerning april/g70, bcma, blys/agp-3, and taci |
| 05/30/2002 | WO2001074780A8 Chemical complex comprising a pyridine carboxy derivative and an h2 histamine receptor antagonist |
| 05/30/2002 | WO2001068888A3 Production of chimeric capsid vectors |
| 05/30/2002 | WO2001066746A3 G-protein coupled receptor related polypeptides |
| 05/30/2002 | WO2001060278A3 Oral therapeutic delivery appliance |
| 05/30/2002 | WO2001042273A3 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders |
| 05/30/2002 | WO2000078952A8 Human rna metabolism proteins (rmep) |
| 05/30/2002 | WO2000052205A8 cDNA FOR HUMAN METHYLENETETRAHYDROFOLATE REDUCTASE |
| 05/30/2002 | US20020065416 Anti-inflammatory agents |
| 05/30/2002 | US20020065315 For therapy and prophylaxis of asthma, cystic fibrosis, chronic obstructive pulmonary disease and rhinorrhea, convulsions, vascular spasms, coronary artery spasms, renal disorders, polycystic kidney disease, bladder spasms, etc. |
| 05/30/2002 | US20020065306 Methods for prevention of ulcers and improving physiological performance |
| 05/30/2002 | US20020065302 Cyclic AMP-specific phosphodiesterase inhibitors |
| 05/30/2002 | US20020065296 Administering heteroarylurea compound for therapy of cytokine mediated diseases and proteolytic enzyme mediated diseases |
| 05/30/2002 | US20020065289 Amino pyrazole derivatives useful for the treatment of obesity and other disorders |
| 05/30/2002 | US20020065285 Aromatic heterocyclic compounds as antiinflammatory agents |
| 05/30/2002 | US20020065276 N-triazolymethyl-piperazine compounds with neurokinin-receptor antagonist activity |
| 05/30/2002 | US20020065272 Olanzapine-N-oxide compositions and methods |
| 05/30/2002 | US20020065269 3-Sulfonylamino-c5 to c8-methyleneimino-2-carboxylic acid compound is effective for prophylaxis and treatment of inflammation, tissue degradation, cancer, fibrosis and related diseases |
| 05/30/2002 | US20020065264 Heterocylic leaving group containing -o-Het, or -s-Het, wherein Heterocyclic rings selected from pyridine, pyrole, furan, pyrimidine or proline derivatives |
| 05/30/2002 | US20020065248 Pyrrolopyrazinones useful as serine protease inhibitors |
| 05/30/2002 | US20020065230 Bis(aminomethyl)carbonyl compounds as inhibitors of cysteine protease (cathepsin K) and serine proteases; bone or cartilage loss, e.g., osteoporosis, periodontitis; antiarthritic agents; rheumatic diseases; gingivitis |
| 05/30/2002 | US20020064856 Novel proteases |
| 05/30/2002 | US20020064823 Nucleotide sequences which code binding protein for use in human therapeutics and gene therapy |
| 05/30/2002 | US20020064571 Inhibits elastase; inhibits inflammations; used for the preparation of a vasoregulatory and or collagen activating medicament and to treat gingivitis. |
| 05/30/2002 | US20020064553 Large liposome composition not increasing ldl levels and method of treating atherosclerosis related thereto |
| 05/30/2002 | US20020064525 Anti-IgE vaccines |
| 05/30/2002 | US20020064524 Formulation for topical non-invasive application in vivo |
| 05/30/2002 | CA2541946A1 Freeze-dried pantoprazole preparation and pantoprazole injection |
| 05/30/2002 | CA2430113A1 Process for preparing aqueous extracts of plants and extracts so obtained |
| 05/30/2002 | CA2430100A1 Antiangiogenic agents |
| 05/30/2002 | CA2429699A1 Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof |
| 05/30/2002 | CA2429649A1 Drugs and foods improving the quality of life and process for producing the same |
| 05/30/2002 | CA2429647A1 Use of thienopyrimidines |
| 05/30/2002 | CA2429645A1 Use of pyrazolo[4,3-d]pyrimidines |
| 05/30/2002 | CA2429630A1 Imidazole and benzimidazole caspase inhibitors and uses thereof |
| 05/30/2002 | CA2429618A1 Rhinologically active substances |
| 05/30/2002 | CA2429605A1 Indol derivative and their use as inhibitors of p38 kinase |
| 05/30/2002 | CA2429579A1 Truncated cd200 |
| 05/30/2002 | CA2429570A1 Pyrimidine derivatives |
| 05/30/2002 | CA2429442A1 Aminothiazoles and their use as adenosine receptor antagonists |
| 05/30/2002 | CA2429326A1 4-(biphenylcarbonylamino)piperidine derivatives as mtp inhibitors |
| 05/30/2002 | CA2428386A1 Use of a triple combination comprising a 5ht3 antagonist, a 5ht4 agonist and a laxative for promoting intestinal lavage |
| 05/30/2002 | CA2428191A1 Acid derivatives useful as serine protease inhibitors |
| 05/30/2002 | CA2427444A1 3-arylindole derivatives and their use as cb2 receptor agonists |
| 05/30/2002 | CA2427330A1 Inhibitors of abc drug transporters at the blood-brain barrier |
| 05/30/2002 | CA2427184A1 Combination comprising an agent decreasing vegf activity and an agent decreasing egf activity |
| 05/30/2002 | CA2398924A1 Isolated human phosphatase proteins, nucleic acid molecules encoding human phosphatase proteins, and uses thereof |
| 05/30/2002 | CA2363951A1 Modulating ramp activity |
| 05/29/2002 | EP1208848A1 Stable lactase compositions |
| 05/29/2002 | EP1208842A2 Regulation of the immune system |
| 05/29/2002 | EP1208839A1 Chelate compound for treating Helicobacter pylori infections |